Anne Moscona Selected Research

Anne Moscona Research Topics

Disease

37	Infections 10/2022 - 07/2005
18	Paramyxoviridae Infections (Parainfluenza) 10/2023 - 07/2005
9	COVID-19 01/2024 - 07/2020
8	Measles 10/2023 - 02/2015
8	Virus Diseases (Viral Diseases) 01/2022 - 05/2009
8	Human Influenza (Influenza) 12/2011 - 08/2004
4	Pneumonia (Pneumonitis) 01/2020 - 06/2008
4	Bronchiolitis 01/2020 - 10/2006
3	Subacute Sclerosing Panencephalitis (SSPE) 01/2021 - 01/2019
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 07/2005
3	Croup 01/2020 - 01/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 11/2014
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2019
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2019
2	Henipavirus Infections 01/2018 - 10/2010
1	Thrombosis (Thrombus) 01/2022
1	Persistent Infection 12/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2012
1	Central Nervous System Diseases (CNS Diseases) 07/2010
1	Vesicular Stomatitis 11/2009
1	Malaria 05/2009
1	Otitis Media 06/2008
1	Influenza in Birds (Avian Flu) 01/2008

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2009
21	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2008
13	Peptides (Polypeptides)IBA 10/2022 - 07/2010
13	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2009
12	VaccinesIBA 01/2024 - 01/2012
10	Neuraminidase (Sialidase)IBA 10/2023 - 09/2005
9	LipopeptidesIBA 10/2022 - 01/2018
7	Carrier Proteins (Binding Protein)IBA 10/2023 - 10/2013
7	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2012
5	Hemagglutinins (Hemagglutinin)IBA 10/2023 - 12/2011
5	CholesterolIBA 12/2013 - 07/2010
5	Oseltamivir (Tamiflu)FDA Link 03/2009 - 08/2004
3	AntibodiesIBA 01/2021 - 07/2020
3	Zanamivir (Relenza)FDA Link 01/2008 - 02/2006
2	AerosolsIBA 10/2022 - 06/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	InterferonsIBA 10/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 07/2020
2	Amino Acids FDA Link 01/2021 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2021 - 07/2020
2	sialic acid receptorIBA 10/2013 - 12/2012
1	Monoclonal AntibodiesIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	LipidsIBA 08/2021
1	Single-Chain AntibodiesIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	HN ProteinIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Protein CIBA 10/2018
1	peptide AIBA 12/2011
1	oplunofuspIBA 07/2010
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2010
1	GliotoxinIBA 11/2009
1	Viral HemagglutininsIBA 07/2009
1	Chloroquine (Aralen)FDA LinkGeneric 05/2009
1	Cell Surface ReceptorsIBA 07/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
2	Intranasal Administration 01/2021 - 11/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2020